Is Sesame Legit? Credentialing and the Compounding Pathway

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

This is an independent editorial review. PlexusDx has no commercial relationship with Sesame or its parent company, and no affiliate links or compensation are involved.

"Is Sesame legit?" is really a question about verification. This review, current as of April 2026, lays out what legitimacy means for a telehealth GLP-1 program, the credentials worth confirming, how the compounding pathway is supposed to work, and the warning signs that separate a sound operator from a risky one.

What "legitimate" means in telehealth GLP-1

Legitimacy in this space is not a single badge; it is a set of checkable traits. A sound program uses state-licensed clinicians, partners with licensed pharmacies, evaluates patients clinically before prescribing, and states its pricing plainly. Sesame (Sesame Care) operates as marketplace telehealth, connecting patients to listed providers — a structure that can be entirely legitimate provided each of those traits holds up on inspection. The question is not whether telehealth prescribing is allowed — it is — but whether a specific operator does it the right way.

Credentialing and licensure to verify

Start with the people and the pharmacies. Confirm that the prescribing clinician holds an active license in your state, and that the dispensing pharmacy is licensed as well. On Sesame's official website you can review the program's current structure. A prescription should follow a genuine clinical evaluation of your intake — weight, history, and current medications — not a checkout-style purchase with no review. Keeping a short record of what you verified, and when, makes it easier to revisit if anything about the program later changes.

The 503A compounding pathway explained

When a program dispenses compounded semaglutide or tirzepatide, it typically works through a 503A compounding pharmacy — a state-licensed pharmacy that prepares a medication for an individual patient under a valid prescription. That pathway is a legitimate part of U.S. pharmacy practice when properly licensed. FDA-approved brand products, by contrast, are dispensed through a retail pharmacy. Knowing which route a program uses is central to judging its legitimacy. A 503A pharmacy compounds for an identified individual, which differs from large-scale manufacturing and carries its own oversight.

Clinical oversight and red flags to watch

Trustworthy programs build in ongoing follow-up for dose titration and side-effect management, and they surface the GLP-1 class safety picture rather than hiding it. Red flags include no clinical evaluation before a prescription, no way to verify licensure, medication with unclear sourcing, and pricing that only appears after you commit. When any of these show up, slow down and verify before purchasing. None of these red flags alone proves a program is illegitimate, but several appearing together is a reasonable signal to look elsewhere.

The genetic layer legitimacy checks miss

Even a fully legitimate program does not read the biology beneath your GLP-1 response. Variants in FTO, GLP1R, MC4R, and TCF7L2 map the metabolic terrain a compound acts on. The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights. It does not predict response and never reads drug response; it adds upstream context a credentialing check cannot. Verifying a program confirms it is trustworthy; genetic context describes the terrain, which no licensure step reports. Not affiliated: PlexusDx has no commercial relationship with Sesame.

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, dispensed through licensed pathways and paired with that genetic context. That pairing is meant to complement credentialing, not replace the verification steps every buyer should still perform.

Related reading on PlexusDx: GLP 1 Drugs, GLP 1 Hormone, What Is GLP 1, GLP 1 What Is.

Frequently Asked Questions

Is Sesame a legitimate telehealth service?

Sesame operates as marketplace telehealth in the GLP-1 space as of April 2026. Legitimacy comes down to checkable traits: licensed clinicians, licensed pharmacy partners, a real clinical evaluation before prescribing, and transparent pricing. Verify each of those on the provider's own site rather than relying on a single label.

Is compounded semaglutide from a program like this legal?

Compounded semaglutide or tirzepatide dispensed through a state-licensed 503A compounding pharmacy under a valid prescription is a legitimate part of U.S. pharmacy practice. The key is that the pharmacy is properly licensed and the prescription follows a genuine clinical evaluation. Confirm the pharmacy pathway before purchasing.

How do I verify a telehealth GLP-1 provider?

Check that the prescribing clinician is licensed in your state, that the dispensing pharmacy is licensed, and that a clinical evaluation precedes any prescription. Look for transparent pricing and ongoing follow-up. Treat missing licensure information, no evaluation, or unclear medication sourcing as reasons to pause.

Does legitimacy mean the program is right for me?

Not necessarily. A program can be entirely legitimate and still not fit your biology or goals. Legitimacy checks confirm credentials, not personal suitability. Upstream genetic context and a conversation with a qualified healthcare provider address whether a given GLP-1 pathway makes sense for you specifically.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.